https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Heart-MS.jpg

Cardiac Surgery Market Analysis, Size, Trends | Europe | 2020-2026 | COVID19 | MedSuite

  • Year: 2020
  • Scope: 2016-2026
  • Region: Europe
  • Pages: 739
  • Published Date: 11/18/2020
  • Type: MedSuite

In 2020, the European cardiac surgery device market size was valued at €2.6 billion, with over 50,000 Transcatheter Aortic Valve Implantation (TAVI) procedures performed. Despite COVID19, the market size is expected to reach an insane €5.6 billion in 2026.

Throughout this medical market research, we analyzed 40 cardiac surgery companies across 15 countries in Europe and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the EU Cardiac Surgery Device market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Procedure Volumes for the European Cardiac Surgery Devices
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Competitive Analysis with Market Shares for Each Segment
  • Market Drivers & Limiters for Each Cardiac Surgery Device Market
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Cardiac Surgery Device Market in Europe
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

EU Cardiac Surgery Market Insights

Minimally invasive heart valve therapies, such as TMVr and TAVI, have driven substantial growth in the total European cardiac surgery market. Companies such as Edwards Lifesciences, Medtronic, Abbott and Boston Scientific are all investing in studies and trials to show that their devices are an effective and safe alternative to open-heart surgery. As of 2019, TAVI devices began receiving CE mark approval for use on low-surgical risk patients, with some models projecting the patient pool increasing by as much as 50%.

EU Cardiac Surgery Market Size By Segment, 2020-2026

Limiting the cardiac surgery market are alternative treatments, causing competition between segments. While the approval of transcatheter aortic valve implantation devices to be used on low-surgical risk patients will have a positive effect on the TAVI market, it will take sales away from the tissue heart valve market. This trend is seen across several devices covered in this report; where one segment is gaining market share, another is losing that share. In particular, the annuloplasty repair device market is hampered by the preference for valve replacement to treat mitral regurgitation.

COVID19 Impact on Cardiac Surgery Market in Europe

The negative impact of COVID-19 on the European cardiac surgery and heart valve device market is expected to be a decrease in the overall market value of approximately 30% in 2020 compared to previously anticipated values. The effects of the pandemic on the cardiac surgery and heart valve device market are expected to vary by market segment. Early in the year, non-emergency or elective surgeries were deferred, followed by PPE shortages and infection control restrictions adding to the delays as well. Despite the large drop in expected market value in 2020, the market is predicted to bounce back in 2021 and return to previously expected levels of growth by 2024.

EU Cardiac Surgery Market Share Analysis

EU Cardiac Surgery Market Share LeadersAbbott led the total European cardiac surgery device market by 2020. The company was strongest in the rapidly expanding transcatheter mitral valve repair (TMVr) market. The MitraClip® transcatheter mitral valve repair system generated nearly half of its overall revenue for 2019.

Edwards Lifesciences took the second-leading spot in the cardiac surgery device market in Europe. The company generated the bulk of its revenue in the high-profile TAVI market but was also present in the tissue heart valve, annuloplasty repair device, and transcatheter mitral valve repair markets.

By 2020, Medtronic was the third-leading competitor in the total European cardiac surgery device market. The company derived the bulk of its revenue from the high-value TAVI market in 2019. Medtronic also has a strong foothold in the lucrative VAD market.

RESEARCH REGIONAL COVERAGE

Throughout this research series, iData Research has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The countries covered are:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Scandinavia (Norway, Finland, Sweden, and Denmark)
  • Switzerland
  • Austria
  • Portugal

Detailed Market Segmentation

Each of the markets below is available for purchase as a standalone report, a MedCore.

  • Procedure Volumes for Cardiac Surgery Market– MedPro – Using a number of databases, internal and external, we’re able to provide you with the volume of cardiac surgery procedures being performed in Europe, including Surgical Heart Valve, Annuloplasty Repair, Transcatheter Mitral Valve Repair, Transcatheter Aortic Valve Implantation procedures and many more.
  • Tissue Heart Valve Market – MedCore – The market is further broken down into segments by:
    • Device Type: Stented, Stentless, and Sutureless/Rapid Deployment;
    • Tissue Type: Xenograft and Allograft.
  • Mechanical Heart Valve Market – MedCore – In-depth analysis of the Mechanical Heart Valve Market.
  • Annuloplasty Repair Device Market – MedCore – The chapter contains a detailed market analysis on the Annuloplasty Repair Device market.
  • Transcatheter Mitral Valve Repair Device Market – MedCore – In-depth analysis of the Transcatheter Mitral Valve Repair Device market.
  • Transcatheter Heart Valve Replacement Market – MedCore – The market analysis provides a closer look at the Transcatheter Aortic Valve Implantation Device Market.
  • On-Pump Coronary Artery Bypass Device Market – MedCore – The market is further broken down into ONCAB Disposables and Perfusion System market segments.
  • Off-Pump Coronary Artery Bypass Device Market – MedCore – The analysis is further segmented by Stabilizer and Positioner Device markets.
  • Autotransfusion Device Market – MedCore – This chapter includes an in-depth analysis of the Anastomosis Assist Device market.
  • Endoscopic Vessel Harvesting Device Market – MedCore – The in-depth analysis of the Endoscopic Vessel Harvesting Device market.
  • Anastomosis Assist Device (AAD) Market – MedCore – The chapter takes a closer look at the
  • Ventricular Assist Device (VAD) Market – MedCore – The market analysis is further broken down by Device Type into Percutaneous and Implantable markets.
  • Intra-Aortic Balloon Pump Market – MedCore – The analysis includes the Intra-Aortic Balloon Pump Catheter and Console markets.
  • Artificial Heart Device Market – MedCore – In-depth analysis of the Artificial Heart Replacement Device market.
  • Patent Foramen Ovale Closure Device Market – MedCore – In-depth look at the  Patent Foramen Ovale Closure Device market.
  • Patent Ductus Arteriosus Closure Device Market – MedCore – In-depth analysis of the Patent Ductus Arteriosus Closure Device market.
  • Atrial Septal & Ventricular Septal Defect Closure Device Market – MedCore – The chapter contains the market analysis categorized by Atrial and Ventricular Septal Defect Closure devices.
  • Left Atrial Appendage Closure Device Market – MedCore – The market is further segmented by Device Type, such as Epicardial and Endocardial Device markets.
  • Preshaped Guidewire Market – MedCore – In-depth analysis of the Patent Foramen Ovale Closure Device market.
  • Cerebral Embolic Protection Device Market – Appendix – The chapter provides a market overview and a discussion on the growth of the Cerebral Embolic Protection Device market.
  • Balloon Valvuloplasty Market – Appendix – The chapter is further broken down my markets for Aortic, Mitral, and Pulmonary devices.
  • Transmyocardial Revascularization (TMR) Device Market – Appendix – The chapter provides an overview of the TMR Single-Use Fibre-Optic Handpiece and TMR Laser Console device markets.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS FOR THE EU CARDIAC SURGERY DEVICES MARKET REPORT SUITE

TABLE OF CONTENTS I
LIST OF FIGURES XV
LIST OF CHARTS XXXIV
EXECUTIVE SUMMARY 1
EUROPEAN CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 11
PROCEDURE NUMBERS 13
MARKETS INCLUDED 15
KEY REPORT UPDATES 17
VERSION HISTORY 17
RESEARCH METHODOLOGY 18
Step 1: Project Initiation & Team Selection 18
Step 2: Prepare Data Systems and Perform Secondary Research 21
Step 3: Preparation for Interviews & Questionnaire Design 23
Step 4: Performing Primary Research 24
Step 5: Research Analysis: Establishing Baseline Estimates 26
Step 6: Market Forecast and Analysis 27
Step 7: Identify Strategic Opportunities 29
Step 8: Final Review and Market Release 30
Step 9: Customer Feedback and Market Monitoring 31

DISEASE OVERVIEW

2.1 BASIC ANATOMY 32
2.2 DISEASE TREATMENTS & DIAGNOSTICS 34
2.2.1 Coronary Artery Disease 34
2.2.2 Myocardial Infarction 34
2.2.3 Angina Pectoris 35
2.2.4 Heart Valve Disease 36
2.2.5 Congestive Heart Failure 36
2.2.6 Aortic Stenosis 37
2.2.7 Degenerative/Functional Mitral Regurgitation 39
2.3 PATIENT DEMOGRAPHICS 40
2.3.1 General Statistics 40

PRODUCT ASSESSMENT

3.1 INTRODUCTION 41
3.2 PRODUCT PORTFOLIOS 41
3.2.1 Tissue Heart Valve Device 41
3.2.2 Mechanical Heart Valve Device 44
3.2.3 Annuloplasty Repair Device 46
3.2.4 Transcatheter Mitral Valve Repair Device 48
3.2.5 Transcatheter Heart Valve Replacement Device 49
3.2.6 Cerebral Embolic Protection Device 51
3.2.7 Balloon Valvuloplasty Device 52
3.2.8 On-Pump Coronary Artery Bypass Device 53
3.2.9 Off-Pump Coronary Artery Bypass Device 55
3.2.10 Autotransfusion Device 56
3.2.11 Endoscopic Vessel Harvesting Device 58
3.2.12 Anastomosis Assist Device 59
3.2.13 Transmyocardial Revascularization Device 60
3.2.14 Ventricular Assist Device 61
3.2.15 Intra-Aortic Balloon Pump Device 62
3.2.16 Artificial Heart Replacement Device 63
3.2.17 Remote Hemodynamic Monitoring System Device 64
3.2.18 Patent Foramen Ovale Device 65
3.2.19 Patent Ductus Arteriosus Closure Device 66
3.2.20 Atrial & Ventricular Septal Defect Device 68
3.2.21 Left Atrial Appendage Closure Device 69
3.2.22 Preshaped Guidewires 70
3.3 REGULATORY ISSUES AND RECALLS 71
3.4 CLINICAL TRIALS 94
3.4.1 Abbott 94
3.4.2 CryoLife 98
3.4.3 Edwards LifeSciences 99
3.4.4 Medtronic 104

EUROPEAN CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW

4.1 INTRODUCTION 105
4.2 CURRENCY EXCHANGE RATE 107
4.3 MARKET OVERVIEW 108
4.4 TREND ANALYSIS BY SEGMENT 118
4.5 DRIVERS AND LIMITERS 123
4.5.1 Market Drivers 123
4.5.2 Market Limiters 124
4.6 COMPETITIVE MARKET SHARE ANALYSIS 126
4.7 MERGERS AND ACQUISITIONS 135
4.8 COMPANY PROFILES 137
4.8.1 Abbott 137
4.8.2 Abiomed 139
4.8.3 AtriCure 140
4.8.4 Boston Scientific 141
4.8.5 CryoLife 142
4.8.6 Edwards LifeSciences 143
4.8.7 LivaNova 144
4.8.8 Getinge 145
4.8.9 Medtronic 146
4.8.10 Teleflex 146
4.8.11 Terumo 148
4.9 SWOT ANALYSIS 149
4.9.1 Abbott 150
4.9.2 Abiomed 151
4.9.3 AtriCure 152
4.9.4 Boston Scientific 153
4.9.5 CryoLife 154
4.9.7 Edwards LifeSciences 155
4.9.8 LivaNova 156
4.9.10 Getinge 157
4.9.11 Medtronic 158
4.9.12 Teleflex 159
4.9.13 Terumo 160

IMPACT OF COVID-19 ON THE EUROPEAN CARDIAC SURGERY AND HEART VALVE DEVICE MARKET

5.1 INTRODUCTION 161
5.2 MULTI-SCENARIO ANALYSIS 163
5.2.1.1 Best Case Scenario 163
5.2.1.2 Base Case Scenario 169
5.2.1.3 Worst Case Scenario 175

COUNTRY PROFILES

6.1 INTRODUCTION 182
6.1.1 Population 182
6.1.2 GDP Per Capita 182
6.1.3 Price Index 182
6.2 GERMANY 183
6.3 FRANCE 184
6.4 UNITED KINGDOM 185
6.5 ITALY 186
6.6 SPAIN 187
6.7 BENELUX 188
6.8 SCANDINAVIA 189
6.9 AUSTRIA 190
6.10 SWITZERLAND 191
6.11 PORTUGAL 192

PROCEDURE NUMBERS

7.1 INTRODUCTION 193
7.2 PROCEDURES 194
7.2.1 Total Cardiac Surgery Procedures 194
7.2.2 Surgical Heart Valve Procedures 199
7.2.2.1 Surgical Heart Valve Procedures by Device Type 199
7.2.2.1.1 Tissue Heart Valve Procedures 201
7.2.2.1.2 Mechanical Heart Valve Procedures 203
7.2.2.2 Tissue Heart Valve Procedures 205
7.2.2.2.1 Stented Tissue Heart Valve Procedures 208
7.2.2.2.2 Stentless Tissue Heart Valve Procedures 210
7.2.2.2.3 Sutureless/Rapid Deployment Tissue Heart Valve Procedures 212
7.2.2.2.4 Tissue Heart Valve Procedures by Valve Type 214
7.2.2.2.5 Tissue Heart Valve Procedures by Tissue Type 221
7.2.2.3 Mechanical Heart Valve Procedures 225
7.2.2.3.1 Total Mechanical Heart Valve Procedures 226
7.2.3 Annuloplasty Repair Procedures 233
7.2.3.1 Mitral Valve Procedures 236
7.2.3.2 Tricuspid Valve Procedures 237
7.2.4 Transcatheter Mitral Valve Repair Procedures 238
7.2.5 Transcatheter Aortic Valve Implantation Procedures 241
7.2.5.1.1 Transcatheter Aortic Valve Implantation Procedures by Approach 242
7.2.5.1.2 Transcatheter Aortic Valve Implantation Procedures by Patient Risk Class 245
7.2.5.1.3 Transcatheter Aortic Valve Implantation Procedures by CEPD 246
7.2.6 Coronary Artery Bypass Graft Procedures 248
7.2.6.1 Total Coronary Artery Bypass Graft Procedures 248
7.2.6.2 ONCAB Procedures 251
7.2.6.3 OPCAB Procedures 252
7.2.1 Autotransfusion Procedures 253
7.2.1.1 Total Autotransfusion Procedures 253
7.2.1.2 Cardiovascular and Other Autotransfusion Procedures 256
7.2.1.3 Orthopedic Autotransfusion Procedures 257
7.2.2 Endoscopic Vessel Harvesting Procedures 258
7.2.2.1 Open Vessel Harvesting Procedures 260
7.2.2.2 Endoscopic Vessel Harvesting Procedures 261
7.2.3 Anastomosis Assist Device Procedures 262
7.2.3.1 Traditional Suture Procedures 264
7.2.3.2 Anastomosis Assist Device Procedures 265
7.2.4 Ventricular Assist Device Procedures 266
7.2.4.1 Total Ventricular Assist Device Procedures 266
7.2.4.2 Percutaneous VAD Procedures 270
7.2.4.3 Implantable VAD Procedures 273
7.2.5 Intra-Aortic Balloon Pump Procedures 276
7.2.6 Artificial Heart Procedures 279
7.2.7 Patent Foramen Ovale Closure Procedures 282
7.2.8 Atrial and Ventricular Septal Defect Device Procedures 285
7.2.8.1 Atrial Septal Defect Closure Procedures 287
7.2.8.2 Ventricular Septal Defect Closure Procedures 288
7.2.9 Left Atrial Appendage Closure Procedures 289
7.2.9.1 Endocardial Procedures 291
7.2.9.2 Epicardial Procedures 292
7.2.9.2.1 Epicardial Clip Procedures 293
7.2.9.2.2 Epicardial Suture Procedures 294

TISSUE HEART VALVE MARKET

8.1 INTRODUCTION 295
8.2 MARKET OVERVIEW 297
8.3 MARKET ANALYSIS AND FORECAST 303
8.3.1 Total Tissue Heart Valve Market 303
8.3.2 Stented Tissue Heart Valve Market 310
8.3.3 Stentless Tissue Heart Valve Market 317
8.3.4 Sutureless/Rapid Deployment Tissue Heart Valve Market 324
8.4 DRIVERS AND LIMITERS 331
8.4.1 Market Drivers 331
8.4.2 Market Limiters 332
8.5 COMPETITIVE MARKET SHARE ANALYSIS 334
MECHANICAL HEART VALVE MARKET 337
9.1 INTRODUCTION 337
9.2 MARKET ANALYSIS AND FORECAST 339
9.3 DRIVERS AND LIMITERS 346
9.3.1 Market Drivers 346
9.3.2 Market Limiters 347
9.4 COMPETITIVE MARKET SHARE ANALYSIS 348

ANNULOPLASTY REPAIR DEVICE MARKET

10.1 INTRODUCTION 351
10.2 MARKET ANALYSIS AND FORECAST 352
10.3 DRIVERS AND LIMITERS 359
10.3.1 Market Drivers 359
10.3.2 Market Limiters 359
10.4 COMPETITIVE MARKET SHARE ANALYSIS 361

TRANSCATHETER MITRAL VALVE REPAIR DEVICE MARKET

11.1 INTRODUCTION 364
11.2 MARKET ANALYSIS AND FORECAST 365
11.3 DRIVERS AND LIMITERS 373
11.3.1 Market Drivers 373
11.3.2 Market Limiters 374
11.4 COMPETITIVE MARKET SHARE ANALYSIS 375

TRANSCATHETER AORTIC VALVE IMPLANTATION DEVICE MARKET

12.1 INTRODUCTION 378
12.2 MARKET ANALYSIS AND FORECAST 379
12.3 DRIVERS AND LIMITERS 387
12.3.1 Market Drivers 387
12.3.2 Market Limiters 388
12.4 COMPETITIVE MARKET SHARE ANALYSIS 390

ON-PUMP CORONARY ARTERY BYPASS DEVICE MARKET

13.1 INTRODUCTION 395
13.2 MARKET OVERVIEW 397
13.3 MARKET ANALYSIS AND FORECAST 402
13.3.1 ONCAB Disposables Market 402
13.3.2 Perfusion System Market 409
13.4 DRIVERS AND LIMITERS 418
13.4.1 Market Drivers 418
13.4.2 Market Limiters 419
13.5 COMPETITIVE MARKET SHARE ANALYSIS 421

For a Full Table of Contents, please contact iData.
The Cardiac Surgery Market Report Suite | Europe | 2020-2026 | COVID19 | MedSuite includes analysis on the following companies currently active in this market:

  • Abbott
  • Abiomed
  • Atricure
  • B. Braun
  • Berlin Heart
  • Biosense Webster
  • BioStable
  • Boston Scientific
  • Carag
  • Cardia
  • Cardio Dimensions
  • Cardio Medical
  • Comed
  • Cook Medical
  • CryoLife
  • Edwards Lifesciences
  • Fresenius
  • Getinge
  • Gore
  • Haemonetics
  • Jarvik Heart
  • JenaValve
  • Labcor
  • Lepu Medical
  • Lifetech Scientific
  • LivaNova
  • Med Europe
  • Medtronic
  • Meril Life Sciences
  • Nipro
  • NVT GmbH
  • Occlutech
  • Reliant
  • Spectrum Medical
  • SynCardia
  • Teleflex
  • Terumo
  • Venus Medtech
  • Vitalitec
  • Zeon Medical Inc

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology